Featured Research

Targeting C5ar1 Shows Early Promise as New Therapy for Gaucher Disease Blocking a molecule that drives inflammation and organ damage in Gaucher disease and other lysosomal storage diseases (lsds) shows potential as less risky, lower-cost alternative to current therapies, according to findings recently published in Nature.